Biopsy Devices Market is predicted to reach US$ 3.84 Billion by 2030. The evolution of biopsy from crude to minimally invasive techniques revolutionized medical diagnostics. It provides critical insights into diseases like cancer and infections and guides treatment selections for better patient effects. It stays pivotal in early detection and remedy techniques, with various devices catering to numerous techniques and anatomical sites, ensuring specific sampling while minimizing discomfort and hazards. Technological advancements enhance accuracy and speed in procedures like fine needle aspiration and core needle biopsy, underscoring their significance in modern-day healthcare.
Further, minimally invasive procedures offer quick recovery and reduced trauma, fueling their popularity. Research shows they are changing invasive surgeries and improving the patient's satisfaction. Rising demand for less invasive surgical procedures and disposable biopsy devices will increase the enterprise. Advanced biopsy steerage systems like vacuum-assisted guns benefit traction among sufferers and carriers. Innovations like Vacora, Finesse Ultra Breast Biopsy System, and Celero VAB gadgets will bolster the boom trajectory of the biopsy devices market.
The worldwide population of older people appreciably drives the increase in the biopsy devices market. With over 760 million individuals aged 65 or older, comprising 9% of the total population, projections indicate an upward push to 1.6 billion by 2050. This trend is said explicitly in low- and middle-profit nations (LMICs), where the over-65 population is ready to increase from 37 million in 2019 to 120 million by 2050. Notably, cancer prevalence peaks at later life stages, with around 50% of instances taking place in people aged 65 or older, according to the GLOBOCAN 2022 report.
Moreover, the fragmented biopsy devices market has numerous players and standard product launches. Companies take advantage of techniques like tech innovations and partnerships. Product launches, collaborations, and growth power market capitalization, facilitating innovation and market admission. In August 2022, Devicor Medical Products, Inc. launched the MammotomeDualCore Dual Stage Core Biopsy System, exemplifying this trend. Hence, the Biopsy Devices Market was worth US$ 2.40 Billion in 2023.
In March 2022- Trivitron Healthcare acquired The Kennedy Company, a leading manufacturer of X-ray shielding materials and acoustic barrier products for radiation protection. The acquisition will help Trivitron serve clients of acquired companies with breast biopsy products in the US.
2. Biopsy Guidance Systems
3. Biopsy Needles
4. Biopsy Forceps
5. Others
2. Lung Biopsy
3. Prostate Biopsy
4. Liver Biopsy
5. Gastroenterology Biopsy
6. Others
2. Stereotactic Guided
3. Ultrasound Guided
4. MRI Guided
5. Others
2. Diagnostic & Imaging Center
3. Others
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
2. Hologic, Inc.
3. Danaher Corporation
4. Becton, Dickinson and Company
5. Boston Scientific Corporation
6. Medtronic plc.
7. Olympus Corporation
8. CONMED Corporation
Biopsy Devices Market is forecasted to rise at a CAGR of 6.94% during 2024 to 2030
The increasing occurrence of cancers globally drives growth within the biopsy devices market. The usage of biopsy devices drives this to diagnose and manage various cancers. According to the World Health Organization (WHO), in 2022, there were an anticipated 20 million new cancer cases and 9.7 million deaths. The number of people who have been alive within five years following a cancer diagnosis is expected to be 53.5 million. About one in 5 people will develop cancer at some stage in their lifetime, and about one in nine guys and one in twelve women will die from the disease.Further, minimally invasive procedures offer quick recovery and reduced trauma, fueling their popularity. Research shows they are changing invasive surgeries and improving the patient's satisfaction. Rising demand for less invasive surgical procedures and disposable biopsy devices will increase the enterprise. Advanced biopsy steerage systems like vacuum-assisted guns benefit traction among sufferers and carriers. Innovations like Vacora, Finesse Ultra Breast Biopsy System, and Celero VAB gadgets will bolster the boom trajectory of the biopsy devices market.
The worldwide population of older people appreciably drives the increase in the biopsy devices market. With over 760 million individuals aged 65 or older, comprising 9% of the total population, projections indicate an upward push to 1.6 billion by 2050. This trend is said explicitly in low- and middle-profit nations (LMICs), where the over-65 population is ready to increase from 37 million in 2019 to 120 million by 2050. Notably, cancer prevalence peaks at later life stages, with around 50% of instances taking place in people aged 65 or older, according to the GLOBOCAN 2022 report.
Moreover, the fragmented biopsy devices market has numerous players and standard product launches. Companies take advantage of techniques like tech innovations and partnerships. Product launches, collaborations, and growth power market capitalization, facilitating innovation and market admission. In August 2022, Devicor Medical Products, Inc. launched the MammotomeDualCore Dual Stage Core Biopsy System, exemplifying this trend. Hence, the Biopsy Devices Market was worth US$ 2.40 Billion in 2023.
Needle-based guns are expected to emerge as one of the top leaders in the global biopsy device market
The biopsy devices market is fragmented by product into Needle-Based Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, and Others. Needle-based guns are poised to be among the global biopsy device market leaders. This is due to their minimally invasive nature, precise tissue sampling abilities, and rapid procedure times. These factors make them favored tools for clinicians performing biopsies, driving their prominence within the biopsy device market.The number of lung biopsies may increase as the global market for biopsy devices grows
The biopsy devices market is segmented based on application into Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Gastroenterology Biopsy, and Others. Lung biopsies might be rising as a developing international biopsy devices market segment. This is attributed to the growing occurrence of lung illnesses, including cancer and infections. The demand for minimally invasive diagnostic processes to correctly assess lung conditions fuels the adoption of lung biopsy devices.There is a possibility of growth for ultrasound technology in the global biopsy devices market
The market for biopsy devices is categorized based on the technology used, including CT scans, stereotactic ultrasounds, MRIs, and other segments. Ultrasound technology is potentially experiencing growth in the global biopsy devices market. This is because of its non-invasive nature, real-time imaging competencies, and ability to guide biopsy processes correctly. With the increasing demand for minimally invasive diagnostic techniques, ultrasound-guided biopsies offer progressed precision and decreased patient pain, propelling biopsy devices market expansion.Diagnostic and imaging facilities are one of the segments gaining traction in the global biopsy devices market
The biopsy devices market is categorized into Hospitals, Diagnostic & Imaging Centers, and Others by end-user. Due to their superior imaging technologies and specialized information, diagnostic and imaging facilities are among the segments gaining traction within the global biopsy devices market. They offer precise guidance and interpretation for biopsy strategies, enhancing diagnostic accuracy and patient care.Asia-Pacific market for biopsy devices is set to experience one of the highest growth rates
This report divides the biopsy devices market by country. The regions included in the report are North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). The Asia-Pacific biopsy devices market is poised for one of the highest growth quotes. This is because of the growing cancer prevalence, considerable populations in countries like China and India, improved healthcare infrastructure, higher healthcare spending, authorities initiatives, and accelerated attention from predominant market players. The Chinese biopsy devices market holds the most significant percentage, while Japan's market is the fastest-growing. For example, Hologic has launched the Brevera Breast Biopsy System with CorLumina Imaging Technology in Japan. The system streamlines imaging and biopsy sample series, reducing the need for multiple devices.Key Players
Cardinal Health, Inc., Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic plc., Olympus Corporation, and CONMED Corporation are the prominent companies in the biopsy devices market.In March 2022- Trivitron Healthcare acquired The Kennedy Company, a leading manufacturer of X-ray shielding materials and acoustic barrier products for radiation protection. The acquisition will help Trivitron serve clients of acquired companies with breast biopsy products in the US.
Product - Market breakup in 5 viewpoints:
1. Needle-Based Guns2. Biopsy Guidance Systems
3. Biopsy Needles
4. Biopsy Forceps
5. Others
Application - Market breakup in 6 viewpoints:
1. Breast Biopsy2. Lung Biopsy
3. Prostate Biopsy
4. Liver Biopsy
5. Gastroenterology Biopsy
6. Others
Technology - Market breakup in 5 viewpoints:
1. CT Scan2. Stereotactic Guided
3. Ultrasound Guided
4. MRI Guided
5. Others
End-User - Market breakup in 3 viewpoints:
1. Hospitals2. Diagnostic & Imaging Center
3. Others
Country - Market of 25 Countries Covered in the Report:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Cardinal Health, Inc.2. Hologic, Inc.
3. Danaher Corporation
4. Becton, Dickinson and Company
5. Boston Scientific Corporation
6. Medtronic plc.
7. Olympus Corporation
8. CONMED Corporation
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Biopsy Devices Market
4. Market Dynamics
6. Market Share - Global Biopsy Devices
7. Product - Biopsy Devices Market
8. Application - Biopsy Devices Market
9. Technology - Biopsy Devices Market
10. End User - Biopsy Devices Market
11. Countries - Biopsy Devices Market
12. Porter’s Five Forces Analysis - Biopsy Devices Market
13. SWOT Analysis - Biopsy Devices Market
14. Key Players Analysis
List of Figure
List of Tables
Companies Mentioned
- Cardinal Health, Inc.
- Hologic, Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Medtronic plc.
- Olympus Corporation
- CONMED Corporation
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 215 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.4 Billion |
| Forecasted Market Value ( USD | $ 3.84 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
